SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Clears Potential Johnson & Johnson Blockbuster Arthritis Drug

April 24, 2009 | 
1 min read
AP -- The Food and Drug Administration has approved a potential blockbuster drug from Johnson & Johnson that fights three forms of arthritis caused by immune-system deficiencies.
FDA Approvals
Johnson & Johnson Family of Companies Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Regulatory
Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
October 30, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of arrow pointing down, away on top of U.S. flag
Job Trends
Almost 1/3 Eyeing Job Options Outside US, BioSpace Finds
October 30, 2025
 · 
4 min read
 · 
Angela Gabriel
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Biosimilars
FDA Proposes Lower Bar for Biosimilar Approvals in Bid To Lower Drug Prices
October 29, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.
Earnings
FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues
October 29, 2025
 · 
2 min read
 · 
Tristan Manalac